Finance

Lists
Q2 2026 earnings • released • EPS miss -116.28% • Revenue miss -4.99%
See results
USNA:NYSE
USANA Health Sciences Inc
$15.47
+3.90%
(+0.58) 1D
$15.47
0.00% (0.00)
After hours
Closed: Aug 7, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for USNA...
Open
$14.99
High
$15.48
Low
$14.80
Mkt. cap
285.62M
Avg. vol.
137.28K
Volume
236.22K
P/E ratio
32.54
52-wk high
$32.32
52-wk low
$14.35
EPS
$0.48
Beta
0.73
Shares outstanding
18.46M
No. of employees
2K
Open
$14.99
High
$15.48
Low
$14.80
Mkt. cap
285.62M
Avg. vol.
137.28K
Volume
236.22K
P/E ratio
32.54
52-wk high
$32.32
52-wk low
$14.35
EPS
$0.48
Beta
0.73
Shares outstanding
18.46M
No. of employees
2K
News stories
From sources across the web
The Chronicle-Journal
The Chronicle-Journal
·
2 days ago
Why USANA (USNA) Stock Is Nosediving
www.theheraldreview.com
www.theheraldreview.com
·
2 days ago
USANA Health: Q2 Earnings Snapshot
Profile
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors. Wikipedia
About USANA Health Sciences Inc
CEOKevin Guest
Employees1.57K
Founded1992
HeadquartersSalt Lake City, Utah, United States
SectorPersonal care products
Websiteusana.com
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Lebiedzinski
Sidoti
Hold
Maintained
$39.00
+152.1%
10/24/2025
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.07 / $0.43
-116.28%miss
Revenue / Est. (USD)
223.27M / 235.00M
-4.99%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Jan 2026
Apr 2026
Jun 2026
Revenue
213.67M
226.20M
250.22M
223.27M
Cost of goods sold
48.82M
49.41M
59.44M
48.34M
Cost of revenue
48.82M
49.41M
59.44M
48.34M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
163.63M
159.54M
176.91M
165.79M
Operating expense
163.63M
159.54M
176.91M
165.79M
Total operating expenses
212.45M
208.95M
236.34M
214.13M
Operating income
1.22M
17.25M
13.87M
9.14M
Other non operating income
41.00K
-14.00K
1.39M
501.00K
EBT including unusual items
1.79M
4.18M
15.46M
-18.90M
EBT excluding unusual items
1.79M
17.61M
15.46M
10.24M
Income tax expense
8.46M
5.77M
8.51M
9.05M
Effective tax rate
471.35%
138.19%
55.00%
-47.89%
Other operating expenses
-
-
-
-
Net income
-6.52M
-1.78M
7.52M
-21.38M
Net profit margin
-3.05%
-0.78%
3.00%
-
Earnings per share
-0.15
0.60
0.61
-0.07
Interest and investment income
578.00K
495.00K
437.00K
595.00K
Interest expense
-49.00K
-123.00K
-240.00K
-
Net interest expenses
529.00K
372.00K
197.00K
595.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
9.14M
25.81M
22.15M
17.42M
Gain or loss from assets sale
95.00K
-2.22M
13.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps